Ranitack 150 mg (Tablet)
Unit Price: ৳ 1.50 (30 x 10: ৳ 450.00)
Strip Price: ৳ 15.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ranitidine hydrochloride |
| Company | Ad din pharmaceuticals ltd |
Title
- Ranitack
Categories
- Medicine
- Gastric Medication
- Digestive Health
Indications
- Active Duodenal Ulcer Treatment
- Benign Gastric Ulcer Treatment
- Ulcer Prevention with NSAID Use
- Post-Operative Stress Ulcer Treatment
- Zollinger-Ellison Syndrome Treatment
- GERD Treatment
- Gastrointestinal Hemorrhage Treatment
- Recurrent Peptic Ulcer Bleeding Prevention
- Pre-Anesthesia Acid Aspiration Risk Prevention
Pharmacology
- Competitive Histamine Blocker
- Inhibition of Gastric Acid Secretion
- No Effect on Pepsin Secretion
- Intrinsic Factor Secretion Inhibition
- Gastrin Serum Level Unaffected
DosageAndAdministration
- 150mg Twice Daily for Duodenal and Gastric Ulcers
- 300mg Once Daily at Night for 4-8 Weeks for Ulcers
- 150mg Twice Daily or 300mg at Bedtime for Reflux Oesophagitis
- 150mg 3 Times Daily for Zollinger-Ellison Syndrome
- 150mg Twice Daily or 300mg at Bedtime for Episodic Dyspepsia
- 150mg Maintenance at Night for Recurrence Prevention
- 2-4mg/kg Twice Daily for Children (Peptic Ulcer)
- 50mg Slow Intravenous Injection Every 6-8 Hours for Haemorrhage Prophylaxis
- 2mg/kg to 4mg/kg Twice Daily for Children Oral Dose
- 25mg Per Hour for Intermittent Intravenous Infusion
- 50mg Slow Intravenous Injection for Aspiration Syndrome Risk Patients
Interaction
- Delayed Absorption with Propantheline Bromide
- Minimal Inhibition of Hepatic Metabolism for Certain Drugs
- Altered Absorption of pH-Dependent Drugs
- Reduced Bioavailability with Antacids
Contraindications
- Hypersensitivity to Ranitidine
SideEffects
- Altered Bowel Habit
- Dizziness
- Rash
- Tiredness
- Reversible Confusional States
- Headache
- Decreased Blood Counts
- Muscle or Joint Pain
PregnancyAndLactation
- Placental Crossing
- No Evidence of Impaired Fertility or Harm to Fetus
- Caution During Lactation
PrecautionsAndWarnings
- Reduced Dosage for Impaired Renal and Hepatic Function Patients
UseInSpecialPopulations
- Similar Ulcer Healing Rates in Elderly Patients
- Similar Adverse Effects Incidence in Elderly Patients
OverdoseEffects
- Specific Action with No Expected Problems from Overdosage
- Symptomatic and Supportive Therapy Recommended
- Possible Hemodialysis Removal
TherapeuticClass
- H2 Receptor Antagonist
Reconstitution
- Ranitack 50mg Dilution for Slow IV Injection
- Ranitack 50mg Dilution for Intermittent Slow IV Infusion
- Ranitack 150mg Dilution for Continuous IV Infusion
StorageConditions
- Cool and Dry Storage
- Protection from Light